Hims & Hers Health HIMS
NYSE HIMS
$33.78 +1.92 (+6.03%)
At close: Aug 21, 2026 · 4:00 PM EDT

Hims & Hers Health (HIMS) Depreciation & Amortization (CF) (2020 - 2026)

Hims & Hers Health (HIMS) posted Depreciation & Amortization (CF) of $22.0 million for Q1 2026, up 21.34% sequentially from $18.1 million in Q4 2025, and up 165.26% YoY from $8.3 million in Q1 2025.

Hims & Hers Health (HIMS) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Hims & Hers Health has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $22.0 million in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 165.26% year-over-year to $22.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.1 million (up 172.06% YoY) and the FY2025 annual result came in at $54.5 million, up 218.95% from the prior year.
  • Depreciation & Amortization (CF) advanced to $22.0 million in Q1 2026 per HIMS's latest filing, from $18.1 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $22.0 million in Q1 2026 and troughed at $900000.0 in Q3 2022.
  • A 5-year average of $5.5 million and a median of $2.8 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • The widest YoY moves for Depreciation & Amortization (CF): up 341.88% in 2022, down 41.79% in 2022.
  • Over 5 years, Depreciation & Amortization (CF) stood at $2.0 million in 2022, then jumped by 32.24% to $2.7 million in 2023, then soared by 128.03% to $6.1 million in 2024, then jumped by 198.5% to $18.1 million in 2025, then rose by 21.34% to $22.0 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $22.0 million, $18.1 million, and $8.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 241.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Hims & Hers Health 7.81 Bn 6.97 Bn 480.80 Mn 10.70 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 10.70 Mn
Jun 30, 2026 10.70 Mn
Mar 31, 2026 21.95 Mn
Mar 31, 2026 21.95 Mn
Dec 31, 2025 18.09 Mn
Dec 31, 2025 18.09 Mn
Sep 30, 2025 8.50 Mn
Sep 30, 2025 8.50 Mn
Jun 30, 2025 7.60 Mn
Jun 30, 2025 7.60 Mn
Mar 31, 2025 8.28 Mn
Mar 31, 2025 8.28 Mn
Dec 31, 2024 6.06 Mn
Dec 31, 2024 6.06 Mn
Sep 30, 2024 3.50 Mn
Sep 30, 2024 3.50 Mn
Jun 30, 2024 2.80 Mn
Jun 30, 2024 2.80 Mn
Mar 31, 2024 3.00 Mn
Mar 31, 2024 3.00 Mn